Healthcare Sales & Marketing Network News: alglucosidase

Searching News Database: alglucosidase

HSMN NewsFeed - 6 Aug 2021
FDA Approves New Treatment for Pompe Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 25 May 2010
Genzyme Receives FDA Approval for Lumizyme for Pompe Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Mar 2010
Genzyme Creates Chief Operating Officer Position
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Apr 2008
Genzyme Provides Update on Myozyme(R) Manufacturing
Biopharmaceuticals

HSMN NewsFeed - 13 Dec 2007
Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
Biopharmaceuticals

HSMN NewsFeed - 4 Oct 2007
Genzyme Receives Approval to Market Elaprase(R) in Japan
Biopharmaceuticals Regulatory

HSMN NewsFeed - 24 Jul 2006
Genzyme Receives Approval for Additional Manufacturing at Ireland Plant
Biopharmaceuticals Regulatory

Return to NewsFeed

Additional items found! 7

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 7 additional stories matching:
alglucosidase
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.